Trevi Therapeutics (TRVI) Balance Sheet: Assets & Liabilities

Trevi Therapeutics (TRVI) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Trevi Therapeutics reported total assets of $193.44M and total liabilities of $10.20M. Shareholders' equity was $183.24M, up 83.9% from $99.64M a year earlier. Total debt stood at $753.00K against $188.26M in cash and short-term investments, a net cash position of $187.51M. That puts debt-to-equity at 0.00, compared with 0.01 a year earlier.

Trevi Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Trevi Therapeutics, Inc. (TRVI) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	18.91	34.10	32.40	12.59	36.83	45.00	57.31	17.17	22.02
Short-Term Investments	169.35	73.53	50.57	107.92	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	188.26	107.62	82.97	120.51	36.83	45.00	57.31	17.17	22.02
Accounts Receivable	0.99	0.53	0.49	0.00	0.24	0.00	0.56	0.18	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.40	0.06
Other Current Assets	3.40	1.27	4.58	2.11	1.13	1.27	1.68	1.44	0.14
Total Current Assets	191.66	109.43	87.55	122.62	37.96	46.27	59.55	18.79	22.16
Non-Current Assets
Property, Plant & Equipment (Net)	0.86	1.23	1.56	0.19	0.18	0.33	0.43	0.15	0.01
Other Non-Current Assets	0.93	0.24	0.30	0.21	0.33	0.53	0.02	1.55	0.05
Total Non-Current Assets	1.78	1.47	1.86	0.40	0.52	0.86	0.45	1.70	0.07
Total Assets	193.44	110.90	89.40	123.02	38.48	47.13	60.00	20.49	22.23
Current Liabilities
Accounts Payable	3.91	3.41	1.81	2.86	2.85	2.02	1.60	0.60	0.54
Short-Term Debt	0.31	0.57	0.31	7.03	5.95	0.11	0.10	0.00	5.29
Current Portion of Long-Term Debt	-	-	-	7.00	5.83	-	-	-	-
Accrued Liabilities	5.53	4.27	3.71	3.52	3.81	3.43	-	-	-
Other Current Liabilities	5.53	6.53	3.71	3.52	0.11	3.43	3.50	2.07	1.30
Total Current Liabilities	9.75	10.51	5.82	13.40	12.72	5.56	5.20	2.68	7.13
Non-Current Liabilities
Long-Term Debt	0.45	0.75	1.03	2.15	8.65	14.10	0.26	1.14	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.20	0.00	0.46	0.33
Total Non-Current Liabilities	0.45	0.75	1.03	2.16	8.68	14.29	0.26	0.51	0.33
Total Liabilities	10.20	11.26	6.86	15.56	21.40	19.85	5.46	3.18	7.45
Stockholders' Equity
Common Stock	0.13	0.09	0.07	0.06	0.03	0.02	0.02	0.10	0.00
Retained Earnings	-329.80	-287.05	-239.13	-210.07	-180.92	-146.98	-114.22	-109.50	-84.43
Accumulated Other Comprehensive Income	0.15	0.06	-0.03	-0.12	0.00	0.00	0.00	-0.05	-0.02
Additional Paid-in Capital	512.77	386.53	321.64	317.59	197.96	174.24	168.75	0.00	0.00
Shares Outstanding	128.31	93.60	68.28	59.94	28.51	-	-	-	-
Total Stockholders' Equity	183.24	99.64	82.55	107.46	17.08	27.28	54.55	17.31	14.78
Total Liabilities & Equity	193.44	110.90	89.40	123.02	38.48	47.13	60.00	20.49	22.23

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Trevi Therapeutics Balance Sheet

How much debt does Trevi Therapeutics have?

Trevi Therapeutics had total debt of $753.00K as of Dec 31, 2025, against $188.26M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $1.32M a year earlier.

What are Trevi Therapeutics's total assets?

Trevi Therapeutics reported total assets of $193.44M as of Dec 31, 2025, up 74.4% from $110.90M a year earlier. Total liabilities were $10.20M.

What is Trevi Therapeutics's shareholders' equity?

Trevi Therapeutics's shareholders' equity was $183.24M as of Dec 31, 2025, or about $1.43 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition